News: OSX Osteopore Raises A$2.9M From Entitlement Offer, page-81

You get that this is a Singapore based company listed in Australia right? And what A*Star is (try and find an Aussie equivalent)?

No, Singapore absolutely the place to do the trial. Let alone a better gateway to Asian mkts. Osteopore has two agreements with A*Star. That is so much than a few R&D rebates as often the case in Australia. It fosters funding, research and commercial collaboration and contracts via the Singapore healthcare network and other academic and commercial entities, both inside and outside Singapore.

They've encouraged collaborations, mentorship, and funding to support around 140 start-ups, half of which are biotechs. Between 2016 and 2022, A*Star startups "incubated" there had raised more than S$950 million in funding. Exactly OSX's problem to date - appalling capital management and difficulties raising capital. This is what I have been yammering on about on here to death ears. A*Star's involvement in OSX is significant.